ablation you can count on - medtronic...1 thermosphere™technology overview emprint™ablation...
TRANSCRIPT
ABLATIONYOU CAN COUNT ON
The Emprint™Ablation System with Thermosphere™ Technology
Technology overview
1 Thermosphere™ Technology Overview
EMPRINT™ABLATION SYSTEMWITH THERMOSPHERE™ TECHNOLOGY
▪ 100 W generator with an intuitive user interface and customizable power settings for simplified set-up and operation
▪ 15 cm, 20 cm, and 30 cm antenna lengths
When it comes to procedure results, achieving sufficient ablative margin is a top predictor of local tumor control1
Tumor
Margin
FOR PATIENTS, MARGIN MATTERS
2 Thermosphere™ Technology Overview
PREDICTABILITY IS THE PROBLEM
Historically, manufacturer ex vivo liver ablation recommendations have not accurately predicted clinical results2,3
Ablation Margins
Radiofrequency
Microwave
Expected Achieved
3 Thermosphere™ Technology Overview
PREDICTABILITY CHALLENGES ARE OVERCOMEBY CONTROLLING ACTIVE HEATING
All thermal ablation devices affect tissue by means of two distinct heating zones –called the active and passive zones
Controlling the active heating zone and minimizing reliance on the passive zone to grow ablation volume increases predictability.
▪ Active heating occurs where the tissue isabsorbing intense electrical energy deliveredfrom the ablation probe.
▪ Passive heating is transfer of heat by thermal conduction or thermal convection into tissues surrounding the ablation probe.
▪ An ablation zone results where the combination of active and passive heatingexceed thermally toxic tissue temperaturesfor a sufficient period of time.
4 Thermosphere™ Technology Overview
MICROWAVE TECHNOLOGY HAS EVOLVED
Over time, microwave technology has evolved, gradually delivering better control of the active heating zone
With next generation Thermosphere™ technology, repeatable, spherical results have arrived.4
NO CONTROLS THERMAL AND FIELD CONTROLS WAVELENGTH CONTROL
5 Thermosphere™ Technology Overview
6 Thermosphere™ Technology Overview
Thermal Control
As the ablation starts elements in the antenna begin to conduct heat. Thermosphere™ technology has thermal control with advanced antenna cooling. This prevents heat from traveling up the antenna shaft and contributing to the ablation zone.
Field Control
Thermosphere™ technology has advanced antenna geometry that focuses energy at the tip of the device into a precise spherical electromagnetic field.
Wavelength Control
As the tissue properties change over time, Thermosphere™ technology uses wavelength control to prevent the microwaves from elongating down the antenna shaft.
THE FIRST AND ONLY TECHNOLOGYWITH THREE TYPES OF CONTROL
ONLY THERMOSPHERE™TECHNOLOGYHAS WAVELENGTH CONTROL
Variable Active Heating Without Wavelength Control Conventional Microwave.
Stable Active Heating With Wavelength Control Thermosphere™Technology.
Wavelength control is unique to next generation microwave ablation technology
It minimizes microwave energy elongation on the radiator. This allows for field control to effectively create a robust and stable spherical electromagnetic field across a range of tissue types.4
DESSICATED TISSUE
LIVER
KIDNEYLUNG
DESSICATED TISSUE
LIVER
KIDNEYLUNG
7 Thermosphere™ Technology Overview
ADVANCED ANTENNA DESIGNENABLES WAVELENGTH CONTROL
Ceramic
Cooling fluid
Polymer plastic
Metal
Fiberglass
Composite
Conventional Microwave Technology
Time zero Time zero
1 minute
5 minutes
5 minutes
Conventional Technology with CeramicLoading Dielectric
Thermosphere™
Technology
1 minute
Time zero
1 minute
5 minutes
8 Thermosphere™ Technology Overview
SO YOU CAN PLAN AND PLACE WITH CONFIDENCE
Conventional Microwave
Probe trajectory planning with elliptical ablations
Thermosphere™Technology
Probe trajectory planning with spherical ablations
Approach option 1
Approach option 1
Approach option 2
Approach option 2
9 Thermosphere™ Technology Overview
AND ACHIEVE TRULY PREDICTABLE OUTCOMESWITH A SINGLE PROBE
Thermosphere™ Technology
100 W, 5 min5
Single Antenna
3.3 cm
±0.5
Conventional Microwave Technology
65 W, 5 min1
Two Antenna Three Antenna
3.3 cm
±0.68
2.27 cm
±0.79
Maximum inscribed diameter was defined as the maximum circle diameter that fits inside the ablation zone, which is more indicative ofthe area that could be treated with the ablation than minimum or maximum diameter.1
10 Thermosphere™ Technology Overview
THE DIFFERENCE IS CLINICALLY PROVEN
Ierardi AM et al.Updates in Surgery
Berber E et al.Surgical Endoscopy
Hoffman T et al.WCIO2015
Howk K et al.WCIO2015
Berber E et al.HPB
Zaidi N et al.Journal ofSurgical Oncology
Chetboun M et al.Journal of Surgical Oncology
Park J et al.WCIO2016
Venkat S et al.CIRSE2016
Takahashi H et al.SSO2017
De Cobelli F et al.Medical Onoclogy
Clinical Article –Liver
Clinical Abstract
Pre-clinicalAbstract
Letter to Editor
20162015 2017
11 Thermosphere™ Technology Overview
REFERENCES
1. Harari CM, Magagna M, Bedoya M, et al. Microwave ablation: Comparison of simultaneous and sequential activation ofmultiple antennas in liver model systems. Radiology. 2015;2:142-151. Data selected from Table 1. Ablation Zone Size,Shape, and Temperature Metrics (In vivo data in porcine liver model using Certus 140 with PR15 antennas, n = 7).
2. Winokur RS, Du JY, Pua BB, et al. Characterization of in vivo ablation zones following percutaneous microwave ablation of the liver with two commercially available devices: Are manufacturer published reference values useful? J Vasc Interv Radiol. 2014;25(12):1939-1946.e1.
3. Tarantino L. Percutaneous ablation of small hepatocellular carcinoma: Comparison of 3 commercially available microwave devices. J Vasc Interv Radiol. 2013; 24(5):759.e1-759.e40.
4. Howk K. Consistent and predictable spherical ablation shape in both liver and lung: Performance of the Emprint™ ablation system with Thermosphere™ technology in an in vivo porcine model [Poster 129]. J Vasc Interv Radiol. 2015; 26:e33-3103.
5. Based on internal test report R0043973_B, in vivo performance testing of the Emprint™ MWA system in a porcine model (porcine liver model, n = 8).
6. Ierardi AM, Mangano A, Floridi C, et al. A new system of microwave ablation at 2450 MHz: Preliminary experience. Updates Surg.2015;67(1):39-45.
7. Berber E. Laparoscopic microwave thermosphere ablation of malignant liver tumors: An initial clinical evaluation. Surg Endosc. 2016;30:692.
8. Hoffman T, Kalia A, McLennan G, et al. Can planning software be used to confirm complete thermal coverage during percutaneous microwave ablations? [Poster 29]. J Vasc Interv Radiol. 2015;26:e33-3103.
9. Chetboun M, Kianmanesh R, Sommacale D, Diebold MD, Piardi T. Complete necrosis after microwave thermosphere ablation of liver metastases from colorectal cancer, histological proof of efficacy. J Surg Oncol. 2016;113(7):843-4.
Thermosphere™ Technology Overview12
10. Berber E. The first clinical application of planning software for laparoscopic microwave thermosphere ablation of malignant liver tumors. HPB. 2015;17(7):632-6.doi: 10.1111/hpb.12423.
11. Zaidi N, Okoh A, Yigitbas H, et al. Laparoscopic microwave thermosphere ablation of malignant liver tumors: An analysis of 53 cases. J Surg Oncol. 2016;113(2):130-134.
12. Park J, Kessler J, Lee A. Early safety and effectiveness of thermosphere microwave ablation (Emprint™) in the percutaneous treatment of perivascular liver tumors [Poster 142]. J Vasc Interv Radiol. 2016;27:e47–e114.
13. Jonhson DT, Dodd GD. Characterization of a microwave ablation device characteristics in a perfused liver model. J Vasc Interv Radiol. 2016;27:e47–e114.
14. Venkat S, Froud T, Salas N, et al. Accuracy evaluation of microwave ablation with the Covidien Emprint™system in hepatocellular carcinoma: do expected volumes correlate with in vivo results. Cardiovasc Intervent Radiol. 2016;39(3):35-386.
15. Takahashi H, Pournik H, Berber E. Local recurrence after laparoscopic microwave Thermosphere™ablation of malignant liver tumors [PF221]. Ann Surg Oncol. 2017;24:S1–S192.
16. De Cobelli F, Marra P, Ratti F, et al. Microwave ablation of liver malignancies: Comparison of effects and early outcomes of percutaneous and intraoperative approaches with different liver conditions. Med Oncol. 2017;34:49.
DISCLAIMER: Animal data is not necessarily indicative of human clinical outcomes.
Thermosphere™ Technology Overview13
REFERENCES
The Emprint™Ablation System with Thermosphere™ Technology
For more information, please visit medtronic.eu/product-catalog
© 2018 Medtronic. All rights reserved. Medtronic, Medtronic logo and Further, Together are trademarks of Medtronic. All other brands are trademarks of a Medtronic company. 18-emea-thermosphere-overview-presentation-2417988
PREDICTABILITYFOR YOU.OPTIONS FOR YOUR PATIENTS.